Kowark, Ana
Felzen, Marc
Ziemann, Sebastian
Wied, Stephanie
Czaplik, Michael
Beckers, Stefan K.
Brokmann, Jörg C.
Hilgers, Ralf-Dieter
Rossaint, Rolf
,
Bartman, J.
Becker, L.
Bozlu, L.
Coburn, M.
Fazlipour, G.
Fitzner, C.
Grüßer, L.
Gunesch, G.-A.
Hess, P.
Holten, M.
Junge, E.
Juppen, Dennis
Kaffanke, S.
Koch, T.
Kranke, P.
Liebens, J.
Müller, M.
Ortmanns, Stephan
Reugels, Martin
Roschanski, Ute
Schroeder, Jane
Stadler, Pia
Tutlies, Carla
Van Waesberghe, Julia
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (DFG RO2000/21-1)
Universitätsklinikum RWTH Aachen
Article History
Received: 20 April 2023
Accepted: 22 June 2023
First Online: 30 June 2023
Declarations
:
: The institutional ethics committee of the University Hospital Aachen has approved (EK 170/15) this trial on 25 November 2015. The ethics committee waived an informed consent for the first step of the trial, the randomisation and assignment to the treatment group, as it occurs before any patient contact to a physician and thus was not feasible. Written informed consent was required and provided at least at hospital admission by all patients who were followed up after randomisation and initial treatment with one of the two EMS.
: MF and SKB report other financial interest with the Medical Direction, Emergency Medical Service, City of Aachen, Germany. MC CB and RR report other financial interest as co-founder of the Docs-in Clouds GmbH. The other authors have no competing interests to declare.